General Info

Depomed is a specialty pharmaceutical company engaged in the development of pharmaceutical products based on its proprietary oral drug delivery technologies. Its primary oral drug delivery system is the patented AcuForm drug delivery technology. The AcuForm technology is a proprietary polymer-based drug delivery platform that provides targeted drug delivery solutions for a wide range of compounds. The technology embraces diffusional, erosional, bilayer and multi-drug systems that can optimize oral drug delivery for both soluble and insoluble drugs. AcuForm is designed to address certain limitations of drug delivery and to provide for orally administered, conveniently dosed, cost-effective drug therapy that provides continuous, controlled delivery of a drug over a multi-hour period. Depomed has headquarters in Menlo Park, Calif.